ACADIA Pharmaceuticals to Present at The JMP Securities CNS Forum on August 19, 2020
August 12 2020 - 9:00AM
Business Wire
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will present at The JMP Securities CNS Forum on Wednesday,
August 19, 2020, at 11:00 a.m. Eastern Time.
The conference will be held virtually. A live webcast of
ACADIA’s presentation will be accessible on the company’s website,
www.acadia-pharm.com, under the investors section and an archived
recording will be available on the website through September 19,
2020.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company focused on the development
and commercialization of innovative medicines to address unmet
medical needs in central nervous system disorders. ACADIA has
developed and commercialized the first and only medicine approved
for the treatment of hallucinations and delusions associated with
Parkinson’s disease psychosis. ACADIA’s development efforts are
focused on pimavanserin for additional neuropsychiatric conditions,
trofinetide for Rett syndrome, and an early-stage muscarinic
receptor program. This press release and further information about
ACADIA can be found at: www.acadia-pharm.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200812005131/en/
Media Contact: ACADIA Pharmaceuticals Inc. Eric Endicott (858)
914-7161 media@acadia-pharm.com
Investor Contact: ACADIA Pharmaceuticals Inc. Mark Johnson, CFA
(858) 261-2771 ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2023 to Apr 2024